Loading…
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
ALLIANCE FOR A STRONGER FDA via ESHAM STRATEGIES LLC
2026 · third_quarter · Q3
Issues related to FDA Congressional Appropriations and workforce
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ALLIANCE FOR A STRONGER FDA via ESHAM STRATEGIES LLC
2026 · second_quarter · Q2
Source: Senate LDA
Issues related to FDA Congressional Budget/Appropriations
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ACCUMULUS SYNERGY, INC. via ESHAM STRATEGIES LLC
2026 · first_quarter · Q1
Issues related to regulatory information exchange policies.
Issues related to regulatory information exchange policies.
Issues related to regulatory information exchange policies.
Issues related to regulatory information exchange policies.
ALLIANCE FOR A STRONGER FDA via ESHAM STRATEGIES LLC
2026 · first_quarter · Q1
Issues related to FDA Congressional Budget/Appropriations
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via ESHAM STRATEGIES LLC
2025 · fourth_quarter · Q4
Issues related to FDA Congressional Budget/Appropriations
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ACCUMULUS SYNERGY, INC. via ESHAM STRATEGIES LLC
2025 · fourth_quarter · Q4
Issues related to regulatory information exchange policies.
Issues related to regulatory information exchange policies.
Issues related to regulatory information exchange policies.
Issues related to regulatory information exchange policies.
ACCUMULUS SYNERGY, INC. via ESHAM STRATEGIES LLC
2025 · fourth_quarter · RR
Issues related to regulatory information exchange policies
Issues related to regulatory information exchange policies
Issues related to regulatory information exchange policies
ALLIANCE FOR A STRONGER FDA via ESHAM STRATEGIES LLC
2025 · third_quarter · Q3
Issues related to FDA Congressional Budget/Appropriations
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via ESHAM STRATEGIES LLC
2025 · second_quarter · Q2
Issues related to FDA Congressional Budget/Appropriations
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via ESHAM STRATEGIES LLC
2025 · first_quarter · Q1
Issues related to FDA Congressional Budget/Appropriations
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
ALLIANCE FOR A STRONGER FDA via ESHAM STRATEGIES LLC
2025 · first_quarter · RR
FDA Congressional Budget/Appropriations
Issues related to regulatory information exchange policies